Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
Source: Sharecast
Miele, who took over as CEO in August 2024, purchased the shares at an average price of 1.38p each, for a total value of £9,660.
Following the purchase, Miele holds a beneficial interest in 7.9m ordinary Genedrive shares, representing approximately 0.49% of the company's issued share capital.
As of 1415 BST, Genedrive shares were up 7.14% at 1.50p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 75,249 @ 42.00p Value: £31,604.58
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
